Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions Initiates Strategic Collaboration with Daxor Corporation to Assist in the Management of Patients with Fluid Overload
EDEN PRAIRIE, Minn. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with Daxor Corporation (NYSE:DXR) to explore potential synergies between the company’s Aquadex FlexFlow ® System and Daxor’s BVA-100 Blood
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Third Quarter Financial Results on November 6, 2018
EDEN PRAIRIE, Minn. , Oct. 30, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2018 financial results will be released on Tuesday, November 6, 2018 . The company will host a conference call and webcast at 9:00 AM EST that morning, during which
View HTML
Toggle Summary CHF Solutions to Present at the Dawson James Securities 4th Annual Small Cap Growth Conference
EDEN PRAIRIE, Minn. , Oct. 24, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced that Claudia Drayton , chief financial officer, will present and meet one-on-one with investors at the Dawson James Securities 4th Annual Small Cap Growth Conference on October 30, 2018 .
View HTML
Toggle Summary CHF Solutions Initiates Strategic Collaboration with NI Medical on Management of Fluid Overloaded Patients
EDEN PRAIRIE, Minn. , Oct. 11, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with NI Medical to explore potential clinical synergies between the company’s Aquadex FlexFlow® System and NI Medical’s NICaS Hemodynamic
View HTML
Toggle Summary CHF Solutions to Attend Southwest Nephrology Conference and Cardio Renal Metabolic Conference
EDEN PRAIRIE, Minn. , Oct. 03, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) today announced that the company will be an exhibitor at the 19 th Annual Southwest Nephrology Conference and 6 th Annual Cardio Renal Metabolic Conference to be held jointly on October 5-6, 2018 at the
View HTML
Toggle Summary CHF Solutions to Present at 2018 Ladenburg Thalmann Healthcare Conference October 2, 2018
EDEN PRAIRIE, Minn. , Sept. 25, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced that John Erb , chairman and CEO will present at the 2018 Ladenburg Thalmann Healthcare Conference and meet one-on-one with investors.  The company will present on Tuesday, October 2, 2018 at The
View HTML
Toggle Summary Recently Presented Data Demonstrate Benefits of CHF Solutions’ Aquadex FlexFlow® System in Managing Fluid Overload in Heart Failure Patients from the United Kingdom
EDEN PRAIRIE, Minn. , Sept. 20, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today results from a poster recently presented by a United Kingdom’s National Health Service hospital that demonstrated ultrafiltration provides a safe and effective alternative means of fluid
View HTML
Toggle Summary CHF Solutions Expands Commercial Focus of Fluid Overloaded Patients into the Post-Cardiovascular Surgery Market
EDEN PRAIRIE, Minn. , Sept. 13, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announced that it is expanding its commercial focus into the post-cardiovascular surgery market, where, like in heart failure, patients often need treatment for fluid overload and have failed diuretic
View HTML
Toggle Summary CHF Solutions, Inc. to Attend the 22nd Annual Scientific Meeting of the Heart Failure Society of America
EDEN PRAIRE, Minn., Sept. 11, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today it will be attending the 22 nd Annual Scientific Meeting of the Heart Failure Society of America (HFSA) at the Gaylord Opryland Hotel and Convention Center in Nashville, Tenn.
View HTML
Toggle Summary CHF Solutions, Inc. Acquires Impedance Technology from Vasamed, Inc.
EDEN PRAIRIE, Minn. , Sept. 05, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today it has acquired the AcQtrac™ System technology from Vasamed, Inc. The AcQtrac System is a patented, non-invasive device designed to measure cardiac and hemodynamic parameters utilizing
View HTML